Reagent Generation for Bioanalytical Method Development on Biologics Therapeutics
This Sources Sought notice seeks information on qualified sources capable of providing reagent generation for bioanalytical method development on biologic therapeutics; it is not a solicitation and will not result in an award. The government is assessing availability and technical capability, including qualified small businesses across categories such as HUBZone, service-disabled veteran-owned, 8(a), veteran-owned, woman-owned, and small disadvantaged businesses, as well as commercial product/service availability, to help determine the acquisition method and whether a set-aside is possible. The requirement relates to NCATS’ Therapeutic Development Branch, which conducts translational research and preclinical development of small molecule and biologic drug candidates through IND filing. TDB operates through collaborations with academia, industry, nonprofits, and NIH, combining in-house staff, partners, and contract research organizations in multidisciplinary matrix teams. Respondents’ information will support acquisition planning only, and the government will not reimburse costs incurred in responding.